VEQUESNA

搜索文档
Phathom Pharmaceuticals(PHAT) - 2024 Q4 - Earnings Call Transcript
2025-03-06 22:32
Phathom Pharmaceuticals (PHAT) Q4 2024 Earnings Call March 06, 2025 08:30 AM ET Company Participants Eric Ciarelli - Head of Investor RelationsTerrie Curran - President & CEOMartin Gilligan - Chief Commercial OfficerMolly Henderson - Chief Financial & Business OfficerJoseph Stringer - Managing Director, Equity ResearchAnnabel Samimy - Managing DirectorChengxiang Liu - Vice President - Equity ResearchAzmi Nabulsi - Co-Founder & COO Conference Call Participants Yatin Suneja - Senior Managing Director, Biotech ...
Phathom Pharmaceuticals (PHAT) Conference Transcript
2025-02-07 00:00
Phathom Pharmaceuticals (PHAT) Conference February 06, 2025 10:00 AM ET Company Participants Azmi Nabulsi - Co-Founder & COOMartin Gilligan - Chief Commercial Officer Conference Call Participants Yatin Suneja - Biotechnology Research Analyst Yatin Suneja Good morning, everyone. My name is Yatin Suneja. I am one of the biotech analysts here at Guggenheim. It is my pleasure to welcome our next presenting company, Fathom, to our SMITCAP Biotech Conference. We have a few members here from the company. We have M ...